STAT3 and neoplasm: Likewise, Yamamoto et al. (55) and Guislain et al. (56) showed that sunitinib could reduce MDSC accumulation in the tumor compartment and improve the suppressive TME through blocking the signal transducer and activator of transcription 3 (STAT3) signaling pathways, thus increasing the apoptotic rate of MDSCs in mice.